Drug Middlemen Face State Probes Over Complex Pricing System

By Robert Langreth Several states are probing pharmacy-benefit managers’ business practices in government-sponsored health programs, adding to the scrutiny the middlemen face in Washington for their

Are independent pharmacies a drug on the market?

By Tiffany Moustakas Vincent Mazzamuto is at a crossroads with his pharmacy. It’s either lay off employees, or risk shutting down. But it’s not that simple.

Change in Medicaid drug pricing could save taxpayers $43M, lawmakers say

By David Reich-Hale New York legislators have passed new regulations that eliminate so-called “spread pricing” on prescription drugs within the Medicaid managed care system, a move

State budget cuts city public health funding by $59M

By Jonathan LaMantia The state’s $175.5 billion budget includes a $59 million cut to public health funding for the city Health Department, Mayor Bill de Blasio

New York eliminates PBM spread pricing

By Chain Drug Review New York’s budget that passed early Monday morning eliminates spread pricing in Medicaid managed care, a common practice which allows prescription drug